Parkinson's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People diagnosed with "clinically confirmed Parkinson's disease" based on the 2015 Movement Disorder Society (MDS) diagnostic guidelines, at any age or gender, whose disease is at an early-to-moderate stage (Hoehn & Yahr stage 2.5 or below)
- People diagnosed with "clinically probable Parkinson's disease" based on the same 2015 MDS guidelines, at any age or gender, also at an early-to-moderate stage (Hoehn & Yahr stage 2.5 or below)
- People with Multiple System Atrophy (MSA) — a condition that develops in adulthood (after age 30), progresses over time, and involves either movement difficulties that respond poorly to Parkinson's medication, or problems with balance and coordination, along with at least one sign of the body's automatic functions not working properly (such as bladder control problems or a significant drop in blood pressure when standing up)
- People with Progressive Supranuclear Palsy (PSP), diagnosed according to specific Chinese clinical guidelines for this condition
- Healthy individuals who are matched in age and gender to the patient groups in the study
Who may not be able to join:
- People who do not give their consent to take part in the study
- People whose Parkinson's-like symptoms are caused by something other than Parkinson's disease itself, such as stroke, blood vessel problems, or medication side effects
- People with severe memory or thinking problems, Alzheimer's disease, ALS (also known as motor neurone disease), or other degenerative brain or nervous system conditions
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Yousheng Xiao, Professor, Guangxi Medical University
Phone: +86 15177196935
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Primary Outcome 1（Accuracy and precision）; Primary Outcome 2（Sensitivity and specificity）
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.